Showing results (121-130 of 217) with videos related to
Sort By:
Pageof 22
Journal of Proteome Research|June 19, 2012
Low dose proteasome inhibition affects alternative splicingSven Bieler, Elke Hammer, Manuela Gesell-Salazar, et al.Journal of Interventional Cardiology|June 1, 2016
Optimized Implantation Height of the Edwards SAPIEN 3 Valve to Minimize Pacemaker Implantation After TAVIMarius Schwerg, Felix Fulde, Henryk Dreger, et al.Biology|June 11, 2026
Deficiency of Inactive Rhomboid Protein 2 (iRhom2) Attenuates Macrophage AtherogenicityCarmen Hannemann, Alica Brettschneider, Phillip van Dijck, et al.Journal of Cardiac Failure|February 9, 2011
The positive inotropic effect of relaxin-2 in human atrial myocardium is preserved in end-stage heart failure: role of G(i)-phosphoinositide-3 kinase signalingThomas Dschietzig, Konstantin Alexiou, Hans-Tilman Kinkel, et al.European Journal of Heart Failure|June 27, 2023
Remote patient management of heart failure across the ejection fraction spectrum: A pre-specified analysis of the TIM-HF2 trialFabian Kerwagen, Kerstin Koehler, Eik Vettorazzi, et al.Cellular Signalling|January 19, 2011
Hypoxia followed by re-oxygenation induces oxidation of tyrosine phosphatasesAsa Sandin, Markus Dagnell, Adrian Gonon, et al.Atherosclerosis|January 10, 2014
LXR agonism improves TNF-α-induced endothelial dysfunction in the absence of its cholesterol-modulating effectsFrank Spillmann, Sophie Van Linthout, Kapka Miteva, et al.Interventional Cardiology Clinics|November 28, 2021
Caval Valve ImplantationAlexander Lauten, Henryk Dreger, Michael Laule, et al.Pacing and Clinical Electrophysiology : PACE|April 24, 2013
Complete atrioventricular block after TAVI: when is pacemaker implantation safe?Marius Schwerg, Gerd Baldenhofer, Henryk Dreger, et al.The Journal of Heart Valve Disease|January 4, 2014
Surgical-transcatheter approach for endocarditis of a calcified aortic homograftHerko Grubitzsch, Michael Laule, Karl Stangl, et al.Pageof 22